Comments
Genlink Pharma Solutions Pvt Ltd has informed BSE about : 1. Standalone Unaudited Financial Results for half year and year ended March 31, 2018 2. Limited Review Report for half year ended March 31, 2018. 3. Disclosure as per Regulation 52(4) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. 4. Certificate from Debenture Trustee under Regulation 52(5) of SEBI (LODR) Regulation, 2015. 5. Submission under Regulation 54(2) of Securities and Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulations, 2015.
Pdf Link: Unaudited Financial Results For The Half Year Ended 31St March 2018.
Source : BSE - www.bseindia.com
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.